Insider Transactions in Q3 2023 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
922
-0.34%
|
$11,986
$13.86 P/Share
|
|
Aug 17
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
668
-0.05%
|
$8,684
$13.86 P/Share
|
|
Aug 17
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,996
-0.42%
|
$38,948
$13.86 P/Share
|
|
Aug 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.67%
|
-
|
|
Aug 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
Aug 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.59%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Bona fide gift
|
Indirect |
570,251
+31.64%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Indirect |
329,963
-43.95%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
240,288
-25.58%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Other acquisition or disposition
|
Indirect |
240,288
+50.0%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Other acquisition or disposition
|
Direct |
240,288
-20.37%
|
-
|